Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2(+/−) Mice Is Superior to Everolimus Alone()

Tuberous sclerosis (TSC) is an inherited tumor syndrome caused by mutations in TSC1 or TSC2 that lead to aberrant activation of mTOR and development of tumors in multiple organs including the kidneys. The mTOR inhibitors rapamycin and everolimus (rapalogs) have demonstrated clinical efficacy in trea...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neoplasia
Huvudupphovsmän: Yang, Jian, Samsel, Paulina A., Narov, Kalin, Jones, Ashley, Gallacher, Daniel, Gallacher, John, Sampson, Julian R., Shen, Ming Hong
Materialtyp: Artigo
Språk:Inglês
Publicerad: Neoplasia Press 2017
Ämnen:
Original article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5238457/
https://ncbi.nlm.nih.gov/pubmed/28092822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2016.12.008
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk